I've been following the Cannabis movement for quite some time.  One of the things supporters of medical cannabis have been waiting for is for Cannabis to be re-scheduled to classify it as a drug that has medicinal value.  Well I've been doing research and I found out that a MS drug known as Sativex made buy a U.K. company is making its way to the FDA and the USA.  It turns out GW Pharma makes Sativex as a derivative of cannabis and it has a different scientific name which is nabiximols.  So we no longer have to wait for 26 states ( a majority) to legalize cannabis for medical use, for the feds to re-schedule. Since nabiximols is considered a different medicine than cannabis sativa, the FDA doesn't have to re-class Cannabis for GWPH and others to create medicines derived from cannabis.  This is great news for the bio-tech cannabis sector ... and not so great for  those who want complete legalization & those who distribute cannabis as a medicine in the bud form. This discovery should have  no impact on for the Charlettes Web strain, and other strains high in CBD's which is so low in THC a slight tweek in the hemp laws could put the anti-seizure strain in hemp category.  Cannabis and derivatives of have a very bright future in the anti-seizure and the MS market.  Once it becomes widely known that there is a safe alternative to the current  powerful and dangerous seizure medicines in the market, there will be a major shift in acceptance.  My guess is this will take a year for derivatives of Cannabis to be mainstream drugs that will be paid for by insurance companies.

where i found this info